全球连续血糖监测龙头企业德康医疗Dexcom公布2025年第四季度财报。公司当季实现营收12.6亿美元，同比增长13%，净利润2.67亿美元，同比增长超过70%，高于市场预期。全球CGM头部企业通过技术迭代、规模优势与生态整合形成壁垒，行业竞争正在从“精度比拼”转向“综合能力比拼”，国内CGM企业需要在数据平台建设和系统整合能力上布局，从硬件制造的传感器更准”转向“谁能成为糖尿病管理系统的核心接口...
Source Link全球连续血糖监测龙头企业德康医疗Dexcom公布2025年第四季度财报。公司当季实现营收12.6亿美元，同比增长13%，净利润2.67亿美元，同比增长超过70%，高于市场预期。全球CGM头部企业通过技术迭代、规模优势与生态整合形成壁垒，行业竞争正在从“精度比拼”转向“综合能力比拼”，国内CGM企业需要在数据平台建设和系统整合能力上布局，从硬件制造的传感器更准”转向“谁能成为糖尿病管理系统的核心接口...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.